Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2022-06-08Appota lands Mirae funding for blockchain initiative
2022-06-07TIAN RUIXIANG Holdings Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
2022-06-07J&T Express Acquires Land in Malaysia
2022-06-06SocietyOne launches transaction & savings accounts powered by Westpac
2022-06-06MoneySmart Encourages Travellers to Have COVID-19 Travel Insurance as a Travel Essential
2022-06-03CGS-CIMB Securities Snags Four FinanceAsia 2022 Awards
2022-06-03SCB powers its path toward digital banking leadership and new era of API-led modernized banking platforms with IBM
2022-06-03CANACCORD GENUITY GROUP INC. REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS
2022-06-02Shoplazza to bring Payoneer Checkout to its 360,000+ merchants
2022-06-02Accountants Direct partners with Annature to streamline eSigning for Corporate and Personal Tax Returns
2022-06-02REALTY ONE GROUP HAILED AS ONE OF THE COUNTRY'S TOP DIVERSE AND RECESSION-PROOF FRANCHISORS
2022-06-01FinVolution Group Reports First Quarter 2022 Unaudited Financial Results
2022-06-01Ascend completes purchase of plant in Chennai
2022-06-01Dalberg strengthens its innovation capabilities through the acquisition of Ravel Innovation
2022-05-31TORCA CONSTRUCTIONS PTY LTD ANNOUNCES AUD9,500,000 SENIOR SECURED LOAN NOTE OFFER
2022-05-31Darlington Building Society enhances regulatory reporting capabilities with Suade's intelligent data driven platform
2022-05-30Illuccix? Reimbursement Milestone and Launch Updates: Pass-Through Status Granted in the U.S.
2022-05-30AMANE ADVISORS MERGES WITH A. VACCANI & PARTNERS AG (AVP), COMBINING LEADING EXPERT ADVISORS IN WATER, RESOURCE RECOVERY AND THE CIRCULAR ECONOMY
2022-05-27Denali Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing May 31, 2022.
2022-05-27Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody? ADG126, with Repeat Dosing Across Dose Levels

First　Previous　81 82 83 84 85　Next　Last　Total 4613 20/Page Page 84 of 231 Go To: